187 related articles for article (PubMed ID: 36230639)
1. Mutation Patterns in Portuguese Families with Hereditary Breast and Ovarian Cancer Syndrome.
Vicente R; Alpuim Costa D; Vitorino M; Mendes AD; Santos C; Fontes-Sousa M
Cancers (Basel); 2022 Sep; 14(19):. PubMed ID: 36230639
[TBL] [Abstract][Full Text] [Related]
2. The role of targeted BRCA1/BRCA2 mutation analysis in hereditary breast/ovarian cancer families of Portuguese ancestry.
Peixoto A; Santos C; Pinto P; Pinheiro M; Rocha P; Pinto C; Bizarro S; Veiga I; Principe AS; Maia S; Castro F; Couto R; Gouveia A; Teixeira MR
Clin Genet; 2015 Jul; 88(1):41-8. PubMed ID: 24916970
[TBL] [Abstract][Full Text] [Related]
3. Using Portuguese BRCA pathogenic variation as a model to study the impact of human admixture on human health.
Andaluz S; Zhao B; Sinha S; Lagniton PNP; Costa DA; Ding X; Brito M; Wang SM
BMC Genomics; 2024 Apr; 25(1):416. PubMed ID: 38671360
[TBL] [Abstract][Full Text] [Related]
4. Screening for BRCA1, BRCA2, CHEK2, PALB2, BRIP1, RAD50, and CDH1 mutations in high-risk Finnish BRCA1/2-founder mutation-negative breast and/or ovarian cancer individuals.
Kuusisto KM; Bebel A; Vihinen M; Schleutker J; Sallinen SL
Breast Cancer Res; 2011 Feb; 13(1):R20. PubMed ID: 21356067
[TBL] [Abstract][Full Text] [Related]
5. BRCA1 and BRCA2 rearrangements in Brazilian individuals with Hereditary Breast and Ovarian Cancer Syndrome.
Ewald IP; Cossio SL; Palmero EI; Pinheiro M; Nascimento IL; Machado TM; Sandes KA; Toralles B; Garicochea B; Izetti P; Pereira ML; Bock H; Vargas FR; Moreira MÂ; Peixoto A; Teixeira MR; Ashton-Prolla P
Genet Mol Biol; 2016; 39(2):223-31. PubMed ID: 27303907
[TBL] [Abstract][Full Text] [Related]
6. Implementation of next-generation sequencing for molecular diagnosis of hereditary breast and ovarian cancer highlights its genetic heterogeneity.
Pinto P; Paulo P; Santos C; Rocha P; Pinto C; Veiga I; Pinheiro M; Peixoto A; Teixeira MR
Breast Cancer Res Treat; 2016 Sep; 159(2):245-56. PubMed ID: 27553368
[TBL] [Abstract][Full Text] [Related]
7. Tumor Testing for Somatic and Germline
Peixoto A; Pinto P; Guerra J; Pinheiro M; Santos C; Pinto C; Santos R; Escudeiro C; Bartosch C; Canário R; Barbosa A; Gouveia A; Petiz A; Abreu MH; Sousa S; Pereira D; Silva J; Teixeira MR
Front Oncol; 2020; 10():1318. PubMed ID: 32850417
[TBL] [Abstract][Full Text] [Related]
8. International distribution and age estimation of the Portuguese BRCA2 c.156_157insAlu founder mutation.
Peixoto A; Santos C; Pinheiro M; Pinto P; Soares MJ; Rocha P; Gusmão L; Amorim A; van der Hout A; Gerdes AM; Thomassen M; Kruse TA; Cruger D; Sunde L; Bignon YJ; Uhrhammer N; Cornil L; Rouleau E; Lidereau R; Yannoukakos D; Pertesi M; Narod S; Royer R; Costa MM; Lazaro C; Feliubadaló L; Graña B; Blanco I; de la Hoya M; Caldés T; Maillet P; Benais-Pont G; Pardo B; Laitman Y; Friedman E; Velasco EA; Durán M; Miramar MD; Valle AR; Calvo MT; Vega A; Blanco A; Diez O; Gutiérrez-Enríquez S; Balmaña J; Ramon y Cajal T; Alonso C; Baiget M; Foulkes W; Tischkowitz M; Kyle R; Sabbaghian N; Ashton-Prolla P; Ewald IP; Rajkumar T; Mota-Vieira L; Giannini G; Gulino A; Achatz MI; Carraro DM; de Paillerets BB; Remenieras A; Benson C; Casadei S; King MC; Teugels E; Teixeira MR
Breast Cancer Res Treat; 2011 Jun; 127(3):671-9. PubMed ID: 20652400
[TBL] [Abstract][Full Text] [Related]
9. BRCA1 and BRCA2 germline mutational spectrum and evidence for genetic anticipation in Portuguese breast/ovarian cancer families.
Peixoto A; Salgueiro N; Santos C; Varzim G; Rocha P; Soares MJ; Pereira D; Rodrigues H; Bento MJ; Fráguas A; Moura G; Regateiro F; Castedo S; Teixeira MR
Fam Cancer; 2006; 5(4):379-87. PubMed ID: 16826315
[TBL] [Abstract][Full Text] [Related]
10. Large regional differences in the frequency of distinct BRCA1/BRCA2 mutations in 517 Dutch breast and/or ovarian cancer families.
Verhoog LC; van den Ouweland AM; Berns E; van Veghel-Plandsoen MM; van Staveren IL; Wagner A; Bartels CC; Tilanus-Linthorst MM; Devilee P; Seynaeve C; Halley DJ; Niermeijer MF; Klijn JG; Meijers-Heijboer H
Eur J Cancer; 2001 Nov; 37(16):2082-90. PubMed ID: 11597388
[TBL] [Abstract][Full Text] [Related]
11. High frequency of pathogenic non-founder germline mutations in
Maksimenko J; Irmejs A; Trofimovičs G; Bērziņa D; Skuja E; Purkalne G; Miklaševičs E; Gardovskis J
Hered Cancer Clin Pract; 2018; 16():12. PubMed ID: 29928469
[TBL] [Abstract][Full Text] [Related]
12. [The limited spectrum of pathogenic BRCA1 and BRCA2 mutations in the French Canadian breast and breast-ovarian cancer families, a founder population of Quebec, Canada].
Tonin PN
Bull Cancer; 2006 Sep; 93(9):841-6. PubMed ID: 16980226
[TBL] [Abstract][Full Text] [Related]
13. Recurrent genetic variants and prioritization of variants of uncertain clinical significance associated with hereditary breast and ovarian cancer in families from the Region of Murcia.
Rosado-Jiménez L; Mestre-Terkemani Y; García-Aliaga Á; Marín-Vera M; Macías-Cerrolaza JA; Sarabia-Meseguer MD; García-Hernández MR; Zafra-Poves M; Sánchez-Henarejos P; Ayala de la Peña F; Alonso-Romero JL; Noguera-Velasco JA; Ruiz-Espejo F
Adv Lab Med; 2023 Sep; 4(3):279-287. PubMed ID: 38075165
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of BRCA1/BRCA2 mutations in a Brazilian population sample at-risk for hereditary breast cancer and characterization of its genetic ancestry.
Fernandes GC; Michelli RA; Galvão HC; Paula AE; Pereira R; Andrade CE; Felicio PS; Souza CP; Mendes DR; Volc S; Berardinelli GN; Grasel RS; Sabato CS; Viana DV; Mauad EC; Scapulatempo-Neto C; Arun B; Reis RM; Palmero EI
Oncotarget; 2016 Dec; 7(49):80465-80481. PubMed ID: 27741520
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of mutations in BRCA and MMR genes in patients affected with hereditary endometrial cancer.
Vietri MT; D'Elia G; Caliendo G; Casamassimi A; Federico A; Passariello L; Cioffi M; Molinari AM
Med Oncol; 2021 Jan; 38(2):13. PubMed ID: 33484353
[TBL] [Abstract][Full Text] [Related]
16. BRCA1 and BRCA2 Germline Mutation Analysis in Hereditary Breast/Ovarian Cancer Families from the Aures Region (Eastern Algeria): First Report.
Mehemmai C; Cherbal F; Hamdi Y; Guedioura A; Benbrahim W; Bakour R; Abdelhak S
Pathol Oncol Res; 2020 Apr; 26(2):715-726. PubMed ID: 30715675
[TBL] [Abstract][Full Text] [Related]
17. Hereditary breast cancer and ancestry in the Madeira archipelago: an exploratory study.
Miguel I; Rodrigues F; Fragoso S; Freixo J; Clara A; Luís A; Bento S; Fernandes M; Bacelar F; Câmara S; Parreira J; Duarte T; Rodrigues P; Santos S; Vaz F
Ecancermedicalscience; 2021; 15():1261. PubMed ID: 34567246
[TBL] [Abstract][Full Text] [Related]
18. [Comparison of hereditary breast and ovarian cancer syndrome and sporadic ovarian cancer in ovarian cancer BRCA mutations].
Duan RR; Sun LX; Zhao HW
Zhonghua Fu Chan Ke Za Zhi; 2021 Nov; 56(11):788-795. PubMed ID: 34823292
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
